Director

Moni Miyashita

Director·Halozyme Therapeutics, Inc.

About

Ms. Miyashita is an independent member of Halozyme's Board of Directors and serves on the Compensation Committee. The Board determined that she is an independent director within the meaning of the applicable rules of the NASDAQ Stock Market. She is not standing for re-election, and her term expires as of the date of the 2026 Annual Meeting.

Also at Halozyme Therapeutics, Inc.

HT Helen I. Torley President and Chief Executive Officer; Director JH Jeffrey W. Henderson Board Chair; Director BC Bernadette Connaughton Director MP Matthew L. Posard Director BD Barbara Duncan Director MK Mahesh Krishnan Director

Roles

Organization Role Dates Details

Halozyme Therapeutics, Inc. Director Present Current role

IBM Vice President, Corporate Development 1998-2011

McKinsey & Company Senior Advisor 2011-2015

Innosight Partner 2015-2019

Related

Company Halozyme Therapeutics, Inc. Company hub Person Helen I. Torley President and Chief Executive Officer; Director Person Jeffrey W. Henderson Board Chair; Director Person Bernadette Connaughton Director Person Matthew L. Posard Director Person Barbara Duncan Director Person Mahesh Krishnan Director Person James Lang Director Person Nicole LaBrosse Senior Vice President, Chief Financial Officer Person Mark Snyder Senior Vice President, Chief Legal Officer Person Cortney Caudill Senior Vice President, Chief Operating Officer Person Michael J. LaBarre Former Senior Vice President, Chief Technical Officer Deal Halozyme Therapeutics Antares Pharma 2022 Deal page Deal Halozyme Therapeutics Elektrofi 2025 Deal page

Source: Halozyme Therapeutics, Inc. SEC filings and official company website

See how VectorShift works for your firm